U.S. General Merchandise and Department Stores Stock News

Halliburton stock has delivered a 79.3% return over the past five years, and the current checks still suggest the shares lean cheap rather than fully priced in. With fresh contracts in Iraq and mixed short term trading, investors are weighing how much of the story is already reflected in the valuation. A 79.3% five year return points to solid longer term shareholder gains, raising the question of how much upside may already be captured in Halliburton's current price. The recent agreement to...

In June 2026, Deluxe Corporation (NYSE: DLX) was added to both the Russell 2000 Defensive Index and the Russell 2000 Value-Defensive Index, highlighting its classification as a smaller-cap company with more defensive, value-oriented characteristics. This dual index inclusion can influence how institutional investors view Deluxe, potentially affecting demand for the shares as index-tracking funds and quantitatively driven portfolios adjust their holdings. Next, we’ll examine how Deluxe’s...

On 27 June 2026, Central Bancompany, Inc. was removed from the Russell 1000 Dynamic Index and added to the Russell 1000 Value-Defensive and Russell 1000 Defensive indices, reshaping its index footprint among large-cap US equities. This reclassification into defensive-oriented benchmarks may influence how institutional investors perceive the bank’s risk profile and adjust their portfolio allocations. Now we’ll explore how Central Bancompany’s shift into Russell 1000 defensive indices affects...

Donaldson Company (DCI) is back in focus after fresh analysis pointed to weak constant currency revenue growth, soft demand and declining returns on capital, raising questions around the stock’s underlying earnings power. See our latest analysis for Donaldson Company. Despite the recent concerns around Donaldson Company’s growth profile, the stock is trading at $87.68 and has eased in the short term, with the share price falling 2.1% over the last day and 1.6% over the past quarter. At the...

Worthington Enterprises, Inc. (NYSE: WOR) was removed from the Russell 2000 Dynamic Index on 27 June 2026, a change that can influence how index funds and benchmarked investors allocate capital to the stock. At the same time, a fresh restricted stock grant to director William Bradley Southern under the 2025 Equity Plan ties board compensation more closely to future company performance and governance continuity. We’ll now examine how Worthington’s removal from the Russell 2000 Dynamic Index...

In the last week, the United States market has stayed flat, yet over the past 12 months, it has risen by an impressive 18%, with earnings expected to grow at a similar rate annually in the coming years. In this context of steady growth and optimistic projections, identifying stocks that are trading below their intrinsic value can offer investors potential opportunities for capitalizing on undervalued assets.

Over the last 7 days, the United States market has remained flat, yet it is up 18% over the past year with earnings forecasted to grow by 18% annually. In this environment, growth companies with high insider ownership can be appealing as they often indicate strong confidence from those closest to the business and potential alignment of interests with shareholders.

In the last week, the market has stayed flat, but over the past 12 months, it has risen by 18%, with earnings expected to grow at a similar rate in the coming years. The term 'penny stocks' might feel like a relic of past market eras, but they still offer potential for growth when backed by strong financials. These smaller or newer companies can provide a mix of affordability and opportunity that larger firms sometimes miss.

Over the last 7 days, the United States market has remained flat, yet over the past 12 months, it has experienced a notable rise of 18%, with earnings expected to grow by an additional 18% annually. In this context of steady growth and potential future gains, identifying reliable dividend stocks offering at least a 3% yield can be an effective strategy for investors seeking both income and stability.

Why Kohl's Credit Agreement Amendment Matters for Stockholders Kohl's (KSS) recently amended its revolving credit facility with Wells Fargo, extending the maturity to June 30, 2031 and revising pricing, availability triggers, and the borrowing base, including new treatment for in transit inventory. This financing move lands against a backdrop of disappointing same store sales over the past two years and limited operating margin profitability. Together, these factors have raised questions...

In early July 2026, Genworth Financial said President and CEO Thomas J. McInerney would take a temporary health-related leave, with CFO Jerome Upton stepping in as interim chief executive, while Enact Holdings reported first-quarter 2026 earnings that beat earnings-per-share forecasts but came in slightly light on revenue. Analysts highlighted that Enact’s stagnant net premiums earned over the past five years and flat near-term sales expectations may limit expansion, especially as mortgage...

In early July 2026, reports of attacks on commercial ships near the Strait of Hormuz and renewed U.S.–Iran tensions pushed global oil prices higher, lifting sentiment across oil and gas producers such as Chord Energy. The episode underscores how quickly geopolitical shocks in critical shipping lanes can alter the revenue outlook for shale-focused operators reliant on crude benchmarks. With oil prices recently boosted by heightened Strait of Hormuz tensions, we’ll examine how this supply...

Geopolitics, oil price swings, and mixed signals from the Federal Reserve have pushed volatility back to the forefront, and that can quickly reshape trading activity across exchanges, options markets, and volatility linked products. Instead of trying to forecast the next headline, it can help to look at which stocks are directly exposed to this surge in hedging and trading demand linked to the latest war escalation between the United States and Iran, the spike in crude oil, and the strength...

EverCommerce Inc. (NasdaqGS:EVCM) was added in June 2026 to several Russell value benchmarks, including the Russell 2000, 2500, 3000, Small Cap Composite, and 3000E Value indices. This broad inclusion across multiple Russell value indices highlights how EverCommerce is now being grouped with value-oriented small and mid-cap peers in key benchmarks tracked by institutional investors. Next, we’ll examine how EverCommerce’s broad Russell value index inclusion may influence its investment...

Vera Therapeutics (VERA) is in focus after the US Food and Drug Administration granted accelerated approval for TRUTAKNA, the company’s first commercial product for adults with primary IgA nephropathy at risk for disease progression. See our latest analysis for Vera Therapeutics. The FDA approval of TRUTAKNA comes after a strong run for Vera Therapeutics, with the 1 year total shareholder return of 74.25% contrasting with a year to date share price return that is down 12.73% and shorter term...

In June 2026, AMN Healthcare Services scheduled an August 6 conference call to discuss its second-quarter 2026 results and third-quarter outlook, while also announcing new commercial and people leadership appointments and highlighting momentum in its Managed Services Program and AI-driven staffing tools. At the same time, investors have been weighing this operational progress against concerns about softening traveler demand, declining earnings per share, and a weaker return on invested...

In early July 2026, Figure Technology Solutions announced a private offering of US$600 million in senior notes, intended primarily to fund its planned acquisition of Kiavi, an AI-powered lending platform for residential real estate investors, with any remaining proceeds earmarked for general corporate purposes. The move to raise guaranteed senior debt while decoupling the notes’ completion from the Kiavi deal underscores Figure’s push to scale its lending marketplace and maintain financing...

Why the latest Azenta event matters for investors Azenta (AZTA) has just completed the previously announced sale of its B Medical Systems business to Thelema S.à r.l. This represents a portfolio shift that places more emphasis on its core life sciences operations. For investors, this completed transaction creates a fresh reference point to reassess how Azenta’s sample management and multiomics segments, which together generated US$596.5 million in revenue, compare with the company’s current...

With bond yields climbing and oil back above $80, investors are again being reminded how quickly macro shocks can hit portfolios. Consumer staples stocks, which sell everyday essentials across markets like the US, UK, Canada, Australia, and New Zealand, can sometimes offer a different risk profile to more cyclical areas when volatility picks up, although that is not guaranteed. This article focuses on our Defensive Consumer Staples screener, built around the latest US Iran tensions and...

In late June 2026, BOK Financial Corporation was removed from the Russell 1000 Dynamic Index, altering its presence in a widely followed benchmark. This index removal may influence how index-tracking funds and benchmark-conscious investors treat BOK Financial within diversified portfolios. We’ll now explore how the loss of Russell 1000 Dynamic Index inclusion could influence BOK Financial’s existing investment narrative and outlook. Invest in the nuclear renaissance through our list of 89...

Constellation Brands (STZ) has drawn fresh attention after first quarter results showed lower sales but higher net income and earnings per share, alongside continued buybacks, a quarterly dividend and new index inclusions. See our latest analysis for Constellation Brands. Despite the solid first quarter earnings beat and continued buybacks, Constellation Brands’ share price has fallen 20.1% over the past three months to US$130.34, and the 1 year total shareholder return has declined 20.8%...

Uranium Energy stock has delivered a very strong 364.0% return over the past 5 years, yet its current valuation checks and premium market multiples suggest the shares are no longer an obvious bargain. A roughly 5 year return of 364.0% points to a stock that has already priced in a lot of optimism about Uranium Energy's future cash generation. The push into U.S. in situ recovery production and a proposed uranium refining and conversion facility can support long term earnings potential, while...

Wave Life Sciences stock has had a tough start to 2026, with a sharp year to date decline set against valuation checks that point to a stock that still looks expensive on traditional measures. Year to date, Wave Life Sciences is down 60.9%, which means recent gains over the past week and month have not yet repaired the earlier damage. Recent progress on its US redomiciliation and RNA programs for obesity and alpha-1 antitrypsin deficiency can support higher growth expectations, but execution...

Ameresco stock has delivered a steep 59.5% decline over the past five years, yet current valuation checks send mixed signals, with the Discounted Cash Flow (DCF) intrinsic value pointing to a premium while earnings-based multiples suggest the shares could be on the cheap side. Over the past 5 years, Ameresco shares are down 59.5%, which sets a cautious backdrop for any argument that the current price already bakes in a recovery story. The prospect of tighter rules on foreign power inverters...